Please login to the form below

Not currently logged in
Email:
Password:

pitavastatin

This page shows the latest pitavastatin news and features for those working in and with pharma, biotech and healthcare.

Recordati snaps up Swiss pharma company Pro Farma

Recordati snaps up Swiss pharma company Pro Farma

The Italian firm has already launched its own oral treatment for disorders of lipoprotein metabolism, Livazo (pitavastatin), on the Swiss market, having been approved for use in adults by the European

Latest news

  • Label change for Lilly's Livalo

    The US Food and Drug Administration (FDA) has said Eli Lilly &Company can update the label of cholesterol drug Livalo (pitavastatin) to remove a warning against the use of the drug

  • Thin on the ground

    Pitavastatin. Livalo (Kowa Pharmaceuticals America, Eli Lilly). Primary hyperlipidaemia or mixed dyslipidaemia.

  • Pharma news in brief

    The Swiss firm said it decided to stop the development of NKS104 (pitavastatin), a lipid lowering statin, as ìdata from recent investigational trials showed the compound was no longer competitive enoughî.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Country report: The healthcare market in Germany Country report: The healthcare market in Germany

    Out of the 10 products assessed last year, four have obtained poor innovation scores: Esbriet (pirfenidone), Livazo (pitavastatin), Yellox (bromfenac) and Trajenta (linagliptin) and a majority of manufacturers have struggled – sometimes

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics